In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States

scientific article

In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1089/APC.2011.0068
P932PMC publication ID3125552
P698PubMed publication ID21992592
P5875ResearchGate publication ID51713058

P50authorGeorge SeageQ90086356
Paige L WilliamsQ92245374
Rohan HazraQ114429001
Ram YogevQ115624602
P2093author name stringJennifer S Read
Raymond Griner
Pediatric HIV/AIDS Cohort Study
Kenneth Rich
Marilyn Crain
P2860cites workCombination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmissionQ33958839
Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy.Q34158407
Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C.Q34170220
Substance use in HIV-Infected women during pregnancy: self-report versus meconium analysisQ34992602
Use of neonatal antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV is decreasing in Western EuropeQ36193276
In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected childrenQ36800856
Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine?Q37491278
Antiretroviral treatment in pregnancy: a six-year perspective on recent trends in prescription patterns, viral load suppression, and pregnancy outcomesQ38450147
Administration of 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) to gravid and infant rhesus macaques (Macaca mulatta): safety and efficacy studiesQ41617111
Trends in management and outcome of pregnancies in HIV-infected women in the UK and Ireland, 1990-2006.Q43544846
Fetal and maternal outcome after administration of tenofovir to gravid rhesus monkeys (Macaca mulatta).Q43901906
Prevention of mother-to-child transmission of HIV in Denmark, 1994-2008.Q46456938
Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected childrenQ80148569
P433issue7
P921main subjectanti-retroviral agentQ50430310
P304page(s)385-394
P577publication date2011-06-10
P1433published inAIDS Patient Care and STDsQ15746602
P1476titleIn utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States
P478volume25

Reverse relations

cites work (P2860)
Q48258648A hierarchical modeling approach for assessing the safety of exposure to complex antiretroviral drug regimens during pregnancy
Q36077016A trigger-based design for evaluating the safety of in utero antiretroviral exposure in uninfected children of human immunodeficiency virus-infected mothers
Q36756151Acylcarnitine Profiles in HIV-Exposed, Uninfected Neonates in the United States
Q35894019Antiretroviral Drugs in Meconium: Detection for Different Gestational Periods of Exposure
Q92082821Antiretroviral Prescribing Practices Among Pregnant Women Living With HIV in the United States, 2008-2017
Q36438846Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design
Q34881120Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers
Q36547343Combination antiretroviral use and preterm birth
Q34860149Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants
Q41922010Darunavir for Use in Pregnant Women with HIV.
Q36800100Development and validation of the first liquid chromatography-tandem mass spectrometry assay for simultaneous quantification of multiple antiretrovirals in meconium
Q37202019Evaluation of risk for late language emergence after in utero antiretroviral drug exposure in HIV-exposed uninfected infants
Q38081072HIV protease inhibitors in pregnancy : pharmacology and clinical use.
Q51365493In utero exposure to antiretrovirals and neurodevelopment among HIV-exposed uninfected children in Botswana.
Q28392255Infant peripheral blood repetitive element hypomethylation associated with antiretroviral therapy in utero
Q54217059Is there a Higher Risk of Mother-to-Child Transmission of HIV Among Pregnant Women with Perinatal HIV Infection?
Q37062155Long-Term Effects of In Utero Antiretroviral Exposure: Systolic and Diastolic Function in HIV-Exposed Uninfected Youth
Q35659264Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy
Q33431825Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir
Q36431061Maternal placental syndromes among women living with HIV in Ontario: a population-based study
Q36951911Meconium Atazanavir Concentrations and Early Language Outcomes in HIV-Exposed Uninfected Infants With Prenatal Atazanavir Exposure
Q35622844Point-of-care capillary blood lactate measurements in human immunodeficiency virus-uninfected children with in utero exposure to human immunodeficiency virus and antiretroviral medications
Q34440361Safety of in utero and neonatal antiretroviral exposure: cognitive and academic outcomes in HIV-exposed, uninfected children 5-13 years of age.
Q37045192Safety of perinatal exposure to antiretroviral medications: developmental outcomes in infants
Q37215994Safety of protease inhibitors in HIV-infected pregnant women
Q34371989Safety of tenofovir during pregnancy for the mother and fetus: a systematic review
Q26744617The PHACS SMARTT Study: Assessment of the Safety of In Utero Exposure to Antiretroviral Drugs
Q57826130Trends in Neonatal Prophylaxis and Predictors of Combination Antiretroviral Prophylaxis in US Infants from 1990 to 2015
Q37587959Trends in antiretroviral drug use during pregnancy among HIV-infected women on medicaid: 2000-2007.

Search more.